|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Review on Ovarian Malignancy |
| Authors Name: | Sejal R. Gotmare , Snehal S. Jadhav , Afroj A. Shaikh |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_183717
|
| Published Paper Id: | IJNRD2211019 |
| Published In: | Volume 7 Issue 11, November-2022 |
| DOI: | |
| Abstract: | Ovarian cancers are the seventh most common cancers are seen in women. It is seen more frequently in old age group women’s. The survival depends on the stage of identification and many of the patient’s present in advanced disease when the prognosis becomes dismal. The dilemma is to distinguish them from benign disease so that the unwanted laparotomies could be saved. Biomarkers and radiological categorization may play a role in categorizing benign from malignant and deciding on the management. There is no screening method to identify ovarian cancers and the patient presents with nonspecific complaints missing them in early stages. Optimal cytoreduction is required for better survival, development free survival and response to adjuvant chemotherapy. Those women having history of breast, ovary, and endometrial, colorectal cancers should be screened for malignancies and genetic testing is advised. Surgery is the mainstay of treatment followed by chemotherapy. Risk decreasing salpingoophorectomy can be offered to women having BRCA1 and BRCA2 mutation carriers after they complete their family. The area of target therapies is the latest and promising in treatment of ovarian cancer. They are coming in forefront when chemotherapy toxicity, drug resistance are big hurdles in treatment of ovarian cancer. Latest advances and understanding of the biology of ovarian cancer have led to clinical trials of targeted agents. The angiogenesis inhibitors and polyadenosine diphosphate-ribose polymerase (PARP) inhibitors are the most developed. |
| Keywords: | Ovarian cancers, Salpingoophorectomy, Neoplasia, PARP, etc. |
| Cite Article: | "A Review on Ovarian Malignancy", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 11, page no.a168-a182, November-2022, Available :http://www.ijnrd.org/papers/IJNRD2211019.pdf |
| Downloads: | 000118754 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2211019 Registration ID: 183717 Published In: Volume 7 Issue 11, November-2022 DOI (Digital Object Identifier): Page No: a168-a182 Country: Ahmednagar , Maharashtra , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2211019 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2211019 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn